{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:05:06Z","timestamp":1784689506476,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960538"],"award-info":[{"award-number":["81960538"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["ZK[2024]481"],"award-info":[{"award-number":["ZK[2024]481"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11307-025-02004-5","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T21:12:11Z","timestamp":1744233131000},"page":"485-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synthesis and Construction of I-124 Labeled Small Molecular Probe for Noninvasive PET Imaging of CAIX Expression"],"prefix":"10.1007","volume":"27","author":[{"given":"Xianteng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"2004_CR1","unstructured":"Shan L, Leung K, Zhang H, Cheng KT, Pagel M (2004) Molecular imaging and contrast agent database (MICAD). Bethesda, MD: National Center for Biotechnology Information"},{"issue":"55","key":"2004_CR2","doi-asserted-by":"publisher","first-page":"94969","DOI":"10.18632\/oncotarget.21662","volume":"8","author":"Z Xu","year":"2017","unstructured":"Xu Z, Li X-F, Zou H et al (2017) 18F-Fluoromisonidazole in tumor hypoxia imaging. Oncotarget 8(55):94969","journal-title":"Oncotarget"},{"key":"2004_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00259-003-1404-x","volume":"31","author":"T Gr\u00f6nroos","year":"2004","unstructured":"Gr\u00f6nroos T, Bentzen L, Marjam\u00e4ki P et al (2004) Comparison of the biodistribution of two hypoxia markers [18 F] FETNIM and [18 F] FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging 31:513\u2013520","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2004_CR4","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s00259-014-2818-3","volume":"41","author":"G Komar","year":"2014","unstructured":"Komar G, Lehti\u00f6 K, Sepp\u00e4nen M et al (2014) Prognostic value of tumour blood flow, [18 F] EF5 and [18 F] FDG PET\/CT imaging in patients with head and neck cancer treated with radiochemotherapy. Eur J Nucl Med Mol Imaging 41:2042\u20132050","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2004_CR5","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3390\/cancers12051322","volume":"12","author":"S Sanduleanu","year":"2020","unstructured":"Sanduleanu S, van der Wiel AM, Lieverse RI et al (2020) Hypoxia PET imaging with [18F]-HX4\u2014a promising next-generation tracer. Cancers (Basel) 12(5):1322","journal-title":"Cancers (Basel)"},{"issue":"1s","key":"2004_CR6","doi-asserted-by":"publisher","first-page":"32s","DOI":"10.18433\/jpps29788","volume":"21","author":"H-S Jans","year":"2018","unstructured":"Jans H-S, Yang X-H, Brocks DR et al (2018) Positron emission tomography (PET) and pharmacokinetics: classical blood sampling versus image-derived analysis of [18F] FAZA and [18F] FDG in a murine tumor bearing model. J Pharm Pharm Sci 21(1s):32s\u201347s","journal-title":"J Pharm Pharm Sci"},{"issue":"3","key":"2004_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2967\/jnumed.113.126615","volume":"55","author":"S Carlin","year":"2014","unstructured":"Carlin S, Zhang H, Reese M et al (2014) A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers. J Nucl Med 55(3):515\u2013521","journal-title":"J Nucl Med"},{"issue":"10","key":"2004_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","volume":"28","author":"A Nocentini","year":"2018","unstructured":"Nocentini A, Supuran C (2018) Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018). Expert Opin Ther Pat 28(10):729\u2013740","journal-title":"Expert Opin Ther Pat"},{"issue":"2","key":"2004_CR9","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3390\/molecules20022323","volume":"20","author":"BP Mahon","year":"2015","unstructured":"Mahon BP, Pinard MA, McKenna RJM (2015) Targeting carbonic anhydrase IX activity and expression. Molecules 20(2):2323\u20132348","journal-title":"Molecules"},{"issue":"1","key":"2004_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb ZJC (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52\u201367","journal-title":"Cell"},{"issue":"41","key":"2004_CR11","doi-asserted-by":"publisher","first-page":"27799","DOI":"10.1074\/jbc.M800938200","volume":"283","author":"M Hilvo","year":"2008","unstructured":"Hilvo M, Baranauskiene L et al (2008) Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes. J Biol Chem 283(41):27799\u201327809","journal-title":"J Biol Chem"},{"issue":"12","key":"2004_CR12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","volume":"27","author":"CT Supuran","year":"2018","unstructured":"Supuran CT (2018) Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Exp Opin Investigat Drugs 27(12):963\u201370","journal-title":"Exp Opin Investigat Drugs"},{"issue":"4","key":"2004_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1470-2045(07)70044-X","volume":"8","author":"CR Divgi","year":"2007","unstructured":"Divgi CR, Pandit-Taskar N, Jungbluth AA et al (2007) Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol 8(4):304\u2013310","journal-title":"Lancet Oncol"},{"issue":"2","key":"2004_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1200\/JCO.2011.41.2445","volume":"31","author":"CR Divgi","year":"2013","unstructured":"Divgi CR, Uzzo RG, Gatsonis C et al (2013) Positron emission tomography\/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. J Clin Oncol 31(2):187\u2013194","journal-title":"J Clin Oncol"},{"issue":"4","key":"2004_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1021\/acs.bioconjchem.5b00105","volume":"26","author":"RM Reilly","year":"2015","unstructured":"Reilly RM, Lam K, Chan C et al (2015) Advancing novel molecular imaging agents from preclinical studies to first-in-humans phase I clinical trials in academia- a roadmap for overcoming perceived barriers. Bioconjug Chem 26(4):625\u2013632","journal-title":"Bioconjug Chem"},{"key":"2004_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00261-015-0599-1","volume":"41","author":"B Turkbey","year":"2016","unstructured":"Turkbey B, Lindenberg ML, Adler S et al (2016) PET\/CT imaging of renal cell carcinoma with 18 F-VM4-037: a phase II pilot study. Abdom Radiol (NY) 41:109\u2013118","journal-title":"Abdom Radiol (NY)"},{"key":"2004_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s11307-015-0831-y","volume":"17","author":"SG Peeters","year":"2015","unstructured":"Peeters SG, Dubois L, Lieuwes NG et al (2015) [18 F] VM4-037 microPET imaging and biodistribution of two in vivo CAIX-expressing tumor models. Mol Imaging Biol 17:615\u2013619","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"2004_CR18","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1021\/acs.molpharmaceut.8b01210","volume":"16","author":"X Yang","year":"2019","unstructured":"Yang X, Zhu H, Yang X et al (2019) Targeting CAIX with [64Cu] XYIMSR-06 small molecular radiotracer enables noninvasive PET imaging of malignant glioma in U87 MG tumor cell xenograft mice. Mol Pharm 16(4):1532\u20131540","journal-title":"Mol Pharm"},{"issue":"35","key":"2004_CR19","doi-asserted-by":"publisher","first-page":"56471","DOI":"10.18632\/oncotarget.10602","volume":"7","author":"I Minn","year":"2016","unstructured":"Minn I, Koo SM, Lee HS et al (2016) [64Cu] XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma. Oncotarget 7(35):56471","journal-title":"Oncotarget"},{"key":"2004_CR20","doi-asserted-by":"publisher","first-page":"33733","DOI":"10.18632\/oncotarget.5254","volume":"6","author":"X Yang","year":"2015","unstructured":"Yang X, Minn I, Rowe S et al (2015) Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor. Oncotarget 6:33733\u201333742","journal-title":"Oncotarget"},{"issue":"2","key":"2004_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1006\/gyno.1998.5163","volume":"71","author":"MA Varia","year":"1998","unstructured":"Varia MA, Calkins-Adams DP, Rinker LH et al (1998) Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol 71(2):270\u2013277","journal-title":"Gynecol Oncol"},{"issue":"1093","key":"2004_CR22","doi-asserted-by":"publisher","first-page":"20170966","DOI":"10.1259\/bjr.20170966","volume":"92","author":"H Tharmalingham","year":"2018","unstructured":"Tharmalingham H, Hoskin P (2018) Clinical trials targeting hypoxia. British J Radiol 92(1093):20170966","journal-title":"British J Radiol"},{"issue":"6","key":"2004_CR23","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2967\/jnumed.115.170514","volume":"57","author":"N Krall","year":"2016","unstructured":"Krall N, Pretto F, Mattarella M et al (2016) A 99mTc-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo. J Nuclear Medic 57(6):943\u2013949","journal-title":"J Nuclear Medic"},{"issue":"3","key":"2004_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2967\/jnumed.120.245530","volume":"62","author":"OC Kulterer","year":"2021","unstructured":"Kulterer OC, Pfaff S, Wadsak W et al (2021) A microdosing study with 99mTc-PHC-102 for the SPECT\/CT imaging of primary and metastatic lesions in renal cell carcinoma patients. J Nuclear Medic 62(3):360\u2013365","journal-title":"J Nuclear Medic"},{"issue":"10","key":"2004_CR25","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1007\/s00259-023-06248-7","volume":"50","author":"W Zhu","year":"2023","unstructured":"Zhu W, Li X, Zheng G et al (2023) Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging 50(10):3116\u20133125","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2004_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.2967\/jnumed.123.267175","volume":"65","author":"MS Hofman","year":"2024","unstructured":"Hofman MS, Tran B, Feldman DR et al (2024) First-in-human safety, imaging, and dosimetry of a carbonic anhydrase IX\u2013Targeting Peptide,[68Ga] Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma. J Nuclear Medic 65(5):740\u2013743","journal-title":"J Nuclear Medic"},{"key":"2004_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejmech.2013.08.005","volume":"69","author":"N Li","year":"2013","unstructured":"Li N, Zhu H, Chu T-w et al (2013) Preparation and biological evaluation of 99mTc-N4IPA for single photon emission computerized tomography imaging of hypoxia in mouse tumor. Eur J Med Chem 69:223\u2013231","journal-title":"Eur J Med Chem"},{"issue":"8","key":"2004_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.clon.2010.06.013","volume":"22","author":"J Staffurth","year":"2010","unstructured":"Staffurth J (2010) A review of the clinical evidence for intensity-modulated radiotherapy. Clinic Oncol 22(8):643\u201357","journal-title":"Clinic Oncol"},{"issue":"5","key":"2004_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2967\/jnumed.123.266309","volume":"65","author":"F Massi\u00e8re","year":"2024","unstructured":"Massi\u00e8re F, Wiedemann N, Borrego I et al (2024) Preclinical characterization of DPI-4452: a 68Ga\/177Lu theranostic ligand for carbonic anhydrase IX. J Nucl Med 65(5):761\u2013767","journal-title":"J Nucl Med"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-025-02004-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T15:34:16Z","timestamp":1749742456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-025-02004-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2004"],"URL":"https:\/\/doi.org\/10.1007\/s11307-025-02004-5","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed all applicable institutional and national guidelines for the care and use of animals. All animal studies protocols were approved by the Peking University Cancer Hospital Animal Care and Use Committee, China (EAEC 2022\u201301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Declarations"}},{"value":"The authors declare that they have no conflict of interest with regard to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}